Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial.
Xu X, Jiang W, Chen L, Xu Z, Zhang Q, Zhu M, Ye P, Li H, Yu L, Zhou X, Zhou C, Chen X, Zheng X, Xu K, Cai H, Zheng S, Jiang W, Wu X, Li D, Chen L, Luo Q, Wang Y, Qu J, Li Y, Zheng W, Jiang Y, Tang L, Xiang C, Li L.
Xu X, et al. Among authors: chen l, chen x.
Clin Transl Med. 2021 Feb;11(2):e297. doi: 10.1002/ctm2.297.
Clin Transl Med. 2021.
PMID: 33634996
Free PMC article.
Clinical Trial.